Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.74 USD | -2.23% | +4.54% | +52.02% |
Chart calendar Kura Oncology, Inc.
Upcoming events on Kura Oncology, Inc.
Past events on Kura Oncology, Inc.
2024-05-15 01:40 pm | BofA Securities Health Care Conference |
2024-05-02 04:30 pm | Q1 2024 Earnings Call |
2024-05-02 04:05 pm | Q1 2024 Earnings Release |
2024-04-17 11:30 am | Stifel Virtual Targeted Oncology Days Conference |
2024-03-14 09:00 am | Barclays Global Healthcare Conference |
2024-03-12 11:20 am | Leerink Partners Global Biopharma Conference |
2024-03-04 09:10 am | TD Cowen Health Care Conference |
2024-02-27 04:30 pm | Q4 2023 Earnings Call |
2024-02-27 04:01 pm | Q4 2023 Earnings Release |
2024-01-30 08:00 am | Investor Meeting |
2023-12-05 02:00 pm | JMP Securities Hematology and Oncology Summit |
2023-11-16 05:30 am | Jefferies London Healthcare Conference |
2023-11-14 11:30 am | Stifel Healthcare Conference |
2023-11-03 12:00 pm | TD Cowen Fall Oncology Innovation Summit |
2023-11-02 04:30 pm | Q3 2023 Earnings Call |
2023-11-02 04:01 pm | Q3 2023 Earnings Release |
2023-10-21 04:15 am | European Society for Medical Oncology Congress |
2023-10-13 12:30 pm | AACR-NCI-EORTC International Conference - Poster Number: B025 |
2023-10-13 12:30 pm | AACR-NCI-EORTC International Conference - Poster Number: B023 |
2023-10-13 12:30 pm | AACR-NCI-EORTC International Conference - Poster Number: B024 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | -67,5 -69,8 3.26% | -91,9 -91,8 -0.11% | -131 -139 6.01% | -139 -158 12.13% | -165 -162 -1.66% | -232 |
EBIT Million USD | Released Forecast Spread | -67,5 -68,3 1.15% | -91,9 -92,4 0.51% | -131 -136 3.72% | -140 -148 5.25% | -166 -163 -1.45% | -231 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -63,1 -64,3 1.82% | -89,6 -89,9 0.28% | -130 -135 3.16% | -136 -145 6.59% | -153 -153 0.17% | -217 |
Net income Million USD | Released Forecast Spread | -63,1 -64,3 1.82% | -89,6 -89,7 0.05% | -130 -134 2.78% | -136 -145 6.17% | -153 -153 0.04% | -217 |
EPS USD | Released Forecast Spread | -1,51 -1,53 1.38% | -1,69 -1,70 0.39% | -1,97 -2,02 2.66% | -2,03 -2,14 5.27% | -2,08 -2,08 0.04% | -2,54 |
Announcement Date | 25/02/20 | 24/02/21 | 24/02/22 | 23/02/23 | 27/02/24 | - |
Quarterly results
Fiscal Period | December | 2020 S1 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
EBITDA Million USD | Released Forecast Spread | -41,4 -41,1 -0.66% | -32,6 -35,2 7.37% | -35,2 -34,7 -1.44% | -36,4 -35,9 -1.54% | -35,0 -53,0 34.08% | -36,4 -36,0 -1% | -39,8 -38,3 -3.89% | -42,3 -41,4 -2.07% | -46,5 -43,8 -6.27% | -54,2 -47,0 -15.36% | -55,3 | -56,1 | -57,3 | ||
EBIT Million USD | Released Forecast Spread | -32,8 -34,5 4.9% | -35,3 -35,0 -0.99% | -36,6 -37,9 3.34% | -35,2 -42,9 18.03% | -36,6 -37,5 2.53% | -40,0 -39,2 -1.98% | -42,5 -41,8 -1.53% | -46,8 -44,6 -4.76% | -54,5 -47,8 -13.93% | -56,4 | -58,6 | -61,1 | -56,6 | -58,4 | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -32,5 -34,2 5.21% | -34,8 -34,8 0.04% | -35,5 -37,7 5.92% | -33,1 -38,9 14.79% | -34,1 -36,6 7.02% | -37,2 -37,8 1.62% | -38,6 -40,4 4.56% | -42,8 -42,4 -0.9% | -49,5 -46,1 -7.47% | -53,7 | -55,9 | -58,3 | -59,1 | -60,4 | |
Net income Million USD | Released Forecast Spread | -32,5 -34,4 5.58% | -34,8 -34,6 -0.4% | -35,5 -37,7 5.73% | -33,1 -38,7 14.54% | -34,1 -36,5 6.63% | -37,2 -37,9 1.95% | -38,6 -40,5 4.74% | -42,8 -42,6 -0.34% | -49,5 -45,3 -9.44% | -53,6 | -55,8 | -57,8 | -57,1 | -58,6 | |
EPS USD | Released Forecast Spread | -0,49 -0,52 5.4% | -0,52 -0,52 -0.48% | -0,53 -0,56 5.99% | -0,49 -0,57 14.53% | -0,50 -0,54 7.92% | -0,53 -0,55 3.64% | -0,50 -0,55 8.95% | -0,55 -0,55 0.3% | -0,59 -0,56 -4.51% | -0,63 | -0,65 | -0,67 | -0,66 | -0,68 | |
Announcement Date | 06/08/20 | 04/05/22 | 03/08/22 | 03/11/22 | 23/02/23 | 10/05/23 | 03/08/23 | 02/11/23 | 27/02/24 | 02/05/24 | - | - | - | - | - |
Past sector events for Kura Oncology, Inc.
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-15 04:01 pm | CELCUITY INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KURA Stock
- Calendar Kura Oncology, Inc.